KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Equity Ratio: 2010-2025

Historic Equity Ratio for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to 0.56.

  • Pacira BioSciences' Equity Ratio rose 13.77% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year increase of 13.77%. This contributed to the annual value of 0.50 for FY2024, which is 9.35% down from last year.
  • Latest data reveals that Pacira BioSciences reported Equity Ratio of 0.56 as of Q3 2025, which was up 13.69% from 0.49 recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Equity Ratio registered a high of 0.56 during Q1 2024, and its lowest value of 0.35 during Q4 2021.
  • Over the past 3 years, Pacira BioSciences' median Equity Ratio value was 0.52 (recorded in 2023), while the average stood at 0.52.
  • Per our database at Business Quant, Pacira BioSciences' Equity Ratio declined by 27.62% in 2021 and then surged by 34.39% in 2023.
  • Quarterly analysis of 5 years shows Pacira BioSciences' Equity Ratio stood at 0.35 in 2021, then spiked by 30.98% to 0.46 in 2022, then climbed by 19.89% to 0.55 in 2023, then dropped by 9.35% to 0.50 in 2024, then rose by 13.77% to 0.56 in 2025.
  • Its Equity Ratio was 0.56 in Q3 2025, compared to 0.49 in Q2 2025 and 0.50 in Q1 2025.